| Serial Number | 79138125 |
| Word Mark | VALNEVA |
| Filing Date | Friday, May 31, 2013 |
| Status | 739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Monday, November 30, 2020 |
| Registration Number | 4686292 |
| Registration Date | Tuesday, February 17, 2015 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 2, 2014 |
| Goods and Services | Pharmaceuticals for human and veterinary use for the treatment of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; antibodies and fragments thereof for use in disease testing; cell cultures, microorganisms and viruses for medical and veterinary use; diagnostic agents for medical, pharmaceutical and veterinary use; cells for medical or clinical use; culture media for cultivating microorganism cells for medical and veterinary use; adjuvants for medical or and veterinary use; pharmaceutical and veterinary preparations for medical, pharmaceutical and veterinary use, namely, preparations of encapsulated cells which release antibodies, living cells and microorganisms, vaccines, viral vectors, proteins, peptides, enzymes, nucleic acids or pharmaceutically active compounds for the treatment of cancer, auto-immune disorders, infectious diseases, inflammatory diseases, neurological and genetic disorders, bowel diseases, and digestion problems |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Chemicals for use in industry, science and agriculture, except fungicides, herbicides, insecticides and parasiticides; molecules from biotechnologies, namely, proteins in raw material for industrial use, scientific or medical research; cells and cell lines for use in scientific, laboratory, or medical research; nucleic acids for laboratory use; proteins in raw material form for scientific and medical research; recombinant proteins in raw material form for scientific and medical research; Biomedical compounds, namely, peptide substrates and peptide antigens used in analyzing and detecting certain toxins for clinical or medical laboratory use; Biochemical preparations derived from blood serum used as growth promoters in tissue cultures and microbiological media; Biochemicals, namely, antibodies and fragments thereof for in vitro scientific or research use; Chemicals for use in biotechnological product development; Cultures of microorganisms other than for medical and veterinary use; Biological preparations and bacteriological preparations for use in cell cultures other than for medical or veterinary use |
| Goods and Services | Scientific research services for medical purposes in the fields of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; scientific research for medical, pharmaceutical and veterinary purposes in the fields of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; scientific research, in particular, in the fields of biology, cellular and molecular biology, biotechnology, bacteriology, immunology, genetics, medicine, pharmacology, virology, chemistry; scientific research relating to vaccines, antibiotics and immunological products for human and veterinary use; research and development of new products for others; testing, analysis, and evaluation of the goods of others to assure compliance with industry standards in the scientific, medical and veterinary fields; development and design of laboratory instruments for scientific and industrial research, in particular, to obtain and prepare cells, cell lines, viruses, proteins, animal and human materials; development of vaccines, antibiotics and immunological products for human and veterinary use; scientific and technological services, namely, diagnostic and prognostic analyses in the fields of cells, cell lines, animal and human materials, microorganisms, molecules for scientific purposes; scientific research, namely, preparation of scientific experts opinions reports |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 13, 2013 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 13, 2013 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 13, 2013 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | VALNEVA |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Saint Herblain F-44800 FR |
| Party Name | VALNEVA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Party Name | VALNEVA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Event Date | Event Description |
| Tuesday, November 19, 2013 | APPLICATION FILING RECEIPT MAILED |
| Monday, November 11, 2013 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, November 13, 2013 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, November 13, 2013 | ASSIGNED TO EXAMINER |
| Friday, November 15, 2013 | NON-FINAL ACTION WRITTEN |
| Saturday, November 16, 2013 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, October 9, 2014 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, November 20, 2013 | REFUSAL PROCESSED BY MPU |
| Wednesday, November 20, 2013 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, December 10, 2013 | REFUSAL PROCESSED BY IB |
| Wednesday, April 9, 2014 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 9, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 9, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 24, 2014 | FINAL REFUSAL WRITTEN |
| Thursday, April 24, 2014 | FINAL REFUSAL E-MAILED |
| Thursday, April 24, 2014 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, October 9, 2014 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, October 9, 2014 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, October 9, 2014 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, October 9, 2014 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 17, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 28, 2014 | ASSIGNED TO LIE |
| Wednesday, October 29, 2014 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, November 12, 2014 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 2, 2014 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 2, 2014 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Sunday, May 17, 2015 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, June 29, 2015 | FINAL DISPOSITION PROCESSED |
| Monday, June 29, 2015 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, July 31, 2015 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, December 22, 2016 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Thursday, December 13, 2018 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Thursday, September 26, 2019 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, February 17, 2020 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Wednesday, July 8, 2020 | TEAS SECTION 71 & 15 RECEIVED |
| Tuesday, November 24, 2020 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Monday, November 30, 2020 | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. |
| Friday, April 7, 2023 | INTERNATIONAL REGISTRATION RENEWED |
| Monday, November 30, 2020 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
| Saturday, October 1, 2022 | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED |
| Saturday, October 15, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, November 3, 2022 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Thursday, April 25, 2024 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Saturday, February 17, 2024 | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED |
| Saturday, February 17, 2024 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
| Sunday, February 25, 2024 | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED |
| Wednesday, May 22, 2024 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED |